Companies /Healthcare

OrganiGram Holdings Inc

NASDAQ: OGI Drug Manufacturers - Specialty & Generic
$0.95
▼ $0.01 (−0.93%) today
Markets closed · 4:20pm ET

OGI at a Glance

Valuation
Market cap
$135.4M
P/E ratio
2.2
Profitability
Revenue (TTM)
$309.2M
Profit margin
28.0%
EPS (TTM)
$0.43
Price
52-week range
$1 – $2
Street target
$8.80

Headquartered in Toronto, ON Fiscal year ends September NASDAQ: OGI organigram.ca

About Organigram Global

Organigram Global Inc. is a licensed cannabis cultivator, producer, and distributor of consumer packaged goods containing cannabis. The company manufactures and distributes cannabis products to wholesale and retail channels in Canada and exports to international jurisdictions. As of Q3 Fiscal 2026, Organigram held the #1 market share position in the Canadian recreational cannabis market. In April 2026, the company acquired Sanity Group GmbH, a German cannabis company with expanding activity in Poland, Czechia, the United Kingdom, and Switzerland, holding approximately 10% market share in the German cannabis market. Organigram operates five cannabis facilities across Canada including the flagship Moncton Campus with 500,000+ square feet of indoor cultivation and manufacturing, the Winnipeg Facility for ingestible products featuring proprietary FAST nanoemulsion technology, the Lac-Supérieur greenhouse facility in Quebec, the Aylmer extraction and manufacturing facility, and the London distribution hub. The company maintains a Product Development Collaboration with British American Tobacco (BAT), its largest institutional shareholder at approximately 48% effective ownership, to develop next-generation cannabis products through a Centre of Excellence. Organigram's brand portfolio spans recreational cannabis (dried flower, pre-rolls, vapes, edibles, and concentrates) sold primarily through Canadian provincial government distributors, and medical cannabis distributed through pharmacies and healthcare partners in Germany, Australia, and the UK via Sanity Group's European platform. The company trades on both NASDAQ and TSX under the symbol OGI. Updated

OGI Coverage

1:32pm ET
Investing

Earnings Previews: OrganiGram, Fastenal

With major earnings reports for the March quarter due to begin next week, we end the current earnings season with quarterly reports for a nuts and bolts company and a marijuana producer.

FAST OGI
Paul Ausick
9:53am ET
Companies and Brands

Cannabis Stocks Scare Off Short Sellers

The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.

ACB CGC OGI
Chris Lange
6:05am ET
Companies and Brands

Resuscitating CannTrust Stock May Not Be Possible

Canadian cannabis grower CannTrust's headwinds include possible delisting from the New York Stock Exchange, overdue financial reports, a class-action lawsuit, black market competition and more.

ACB CGC OGI
Paul Ausick
1:40pm ET
Companies and Brands

How Organigram Stock Can Get Its Mojo Back

Canadian cannabis stocks have performed poorly, in due to the sharp drop in share prices that marijuana stocks suffered last year. Yet, Organigram seemed to be positioned for a better year in…

ACB CGC MO
Paul Ausick
Load More

Frequently Asked Questions

What does Organigram Global do?

Organigram Global Inc. is a licensed cannabis cultivator, producer, and distributor of consumer packaged goods containing cannabis. The company manufactures and distributes cannabis products to wholesale and retail channels in Canada and exports to international jurisdictions.

What is the OGI stock price target?

The Wall Street consensus 12-month price target for OGI is $8.80.